Rare diseases
Investigational molecules
Locations
Back to France30 clinical trials in Bourg En Bresse, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceStudy of Camizestrant and Abemaciclib in Patients with ER‑positive HER2‑negative Metastatic Breast Cancer Who Show Rising ctDNA
FranceA study to evaluate the safety and effectiveness of nivolumab and imiquimod in adults with vulvar squamous cell carcinoma
FranceA study testing inhaled amikacin compared to placebo in critically ill patients with ventilator-associated tracheobronchitis
FranceStudy on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant
FranceStudy on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia
FranceStudy of inhaled interferon beta-1a (SNG001) for treatment of patients with viral lower respiratory tract infections who require mechanical ventilation
FranceStudy Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy
FranceStudy of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
FranceTitle: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment
FranceStudy Comparing Chemotherapy and Abemaciclib with Hormone Therapy for Patients with ER+ HER2- Metastatic Breast Cancer with Visceral Involvement
FranceStudy of hydrocortisone and fludrocortisone combination versus placebo in adults with sepsis in intensive care unit to determine corticosteroid response
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research examining multiple myeloma treatments, including studies of elranatamab-lenalidomide combinations and evaluation of daratumumab therapies. Investigations focus on optimizing treatment duration and improving patient outcomes.
Several trials are exploring personalized approaches for both newly diagnosed and relapsed cases.
Comprehensive studies focusing on breast cancer treatments, particularly in HER2-negative and hormone-receptor-positive cases. Research includes innovative approaches to hormone therapy and targeted treatments.
Trials aim to personalize treatment approaches and improve long-term outcomes.
Important studies in intensive care focusing on respiratory support and sepsis management. Research includes evaluation of high-flow nasal oxygen therapy protocols and corticosteroid treatments.
These trials aim to improve critical care outcomes and standardize treatment approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
